| Takeda Pharma AG - TAKHZYRO 150 mg, Injektionslösung in einer Fertigspritze |
| 68178 | | 02 | | TAKHZYRO 150 mg | | Injektionslösung in einer Fertigspritze | | B06AC05 | | Lanadelumab | | 11.04.2024 | | |
|
| Composition |
| lanadelumabum 150 mg, dinatrii phosphas dihydricus, acidum citricum monohydricum, histidinum, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.46 mg. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | Active Agent | Dose |
|---|
| Lanadelumabum | 150 mg/ml |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Disodium Phosphate Dihydrate | | Histidine | | Sodium Chloride | | Polysorbatum 80 |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | | PR | PR | B | | No |
|
